Severe health conditions decline in childhood cancer survivorsJune 3, 2017Patient & Survivor CarePediatricsHodgkin LymphomaAggressive Lymphomas
FDA panel backs licensure for epoetin alfa biosimilarMay 26, 2017Patient & Survivor CareAnemiaMultiple Myeloma
Fighting in a passive manner active against Clostridium difficileMay 24, 2017Cellular TherapyPatient & Survivor Care
Extended maraviroc helps prevent graft-versus-host diseaseApril 21, 2017AMLPatient & Survivor CareMyelodysplastic Syndrome
Biomarker algorithm sharpens GVHD treatment outcomes predictionApril 18, 2017Cellular TherapyPatient & Survivor Care
Three factors linked to rhinovirus pneumonia in HCT patientsApril 8, 2017Cellular TherapyPatient & Survivor Care
Evidence for medical marijuana largely up in smokeApril 7, 2017Patient & Survivor CareBusiness of Medicine
Off-the-shelf T cells an option for post-HCT viral infectionsApril 5, 2017Cellular TherapyPatient & Survivor Care
Unavoidable, random DNA replication errors are the most common cancer driversMarch 23, 2017PediatricsPatient & Survivor CareHodgkin LymphomaMantle Cell Lymphoma
Connective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017Patient & Survivor CareAggressive Lymphomas
Follistatin, endoglin predict postallogeneic HCT NRMFebruary 27, 2017Cellular TherapyPatient & Survivor Care
Older AML patients benefit from frailty assessment and interventionsFebruary 25, 2017AMLPatient & Survivor Care
Fewer post-transplant CMV infections with novel antiviral prophylaxisFebruary 24, 2017Transfusion MedicinePatient & Survivor Care
